Comment on ‘Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion’

por Huo, Teh-Ia, Liu, Po-Hong, Hsu, Chia-Yang
Publicado 2017

Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization

por Ho, Shu-Yein, Liu, Po-Hong, Hsu, Chia-Yang, Huang, Yi-Hsiang, Liao, Jia-I, Su, Chien-Wei, Hou, Ming-Chih, Huo, Teh-Ia
Publicado 2023

Hepatocellular Carcinoma Patients With Performance Status 1 Deserve New Classification and Treatment Algorithm in the BCLC System

por Hsu, Chia-Yang, Liu, Po-Hong, Lee, Yun-Hsuan, Hsia, Cheng-Yuan, Huang, Yi-Hsiang, Chiou, Yi-You, Lin, Han-Chieh, Huo, Teh-Ia
Publicado 2015

A New Tumor Burden Score and Albumin–Bilirubin Grade-Based Prognostic Model for Hepatocellular Carcinoma

por Ho, Shu-Yein, Liu, Po-Hong, Hsu, Chia-Yang, Huang, Yi-Hsiang, Liao, Jia-I, Su, Chien-Wei, Hou, Ming-Chih, Huo, Teh-Ia
Publicado 2022

Radiofrequency Ablation versus Transarterial Chemoembolization for Hepatocellular Carcinoma within Milan Criteria: Prognostic Role of Tumor Burden Score

por Ho, Shu-Yein, Liu, Po-Hong, Hsu, Chia-Yang, Huang, Yi-Hsiang, Liao, Jia-I, Su, Chien-Wei, Hou, Ming-Chih, Huo, Teh-Ia
Publicado 2022

Prognostic Prediction for Patients with Hepatocellular Carcinoma and Ascites: Role of Albumin-Bilirubin (ALBI) Grade and Easy (EZ)-ALBI Grade

por Liao, Jia-I, Ho, Shu-Yein, Liu, Po-Hong, Hsu, Chia-Yang, Huang, Yi-Hsiang, Su, Chien-Wei, Hou, Ming-Chih, Huo, Teh-Ia
Publicado 2023

A New Treatment-integrated Prognostic Nomogram of the Barcelona Clinic Liver Cancer System for Hepatocellular Carcinoma

por Hsu, Chia-Yang, Liu, Po-Hong, Hsia, Cheng-Yuan, Lee, Yun-Hsuan, Nagaria, Teddy S., Lee, Rheun-Chuan, Ho, Shu-Yein, Hou, Ming-Chih, Huo, Teh-Ia
Publicado 2017

Surgical resection versus transarterial chemoembolization for patients with hepatocellular carcinoma beyond Milan criteria: prognostic role of tumor burden score

por Ho, Shu-Yein, Liu, Po-Hong, Hsu, Chia-Yang, Huang, Yi-Hsiang, Lei, Hao-Jan, Liao, Jia-I, Su, Chien-Wei, Hou, Ming-Chih, Huo, Teh-Ia
Publicado 2023

Decrypting Cryptogenic Hepatocellular Carcinoma: Clinical Manifestations, Prognostic Factors and Long-Term Survival by Propensity Score Model

por Hsu, Chia-Yang, Lee, Yun-Hsuan, Liu, Po-Hong, Hsia, Cheng-Yuan, Huang, Yi-Hsiang, Lin, Han-Chieh, Chiou, Yi-You, Lee, Fa-Yauh, Huo, Teh-Ia
Publicado 2014

Using Serum α-Fetoprotein for Prognostic Prediction in Patients with Hepatocellular Carcinoma: What is the Most Optimal Cutoff?

por Hsu, Chia-Yang, Liu, Po-Hong, Lee, Yun-Hsuan, Hsia, Cheng-Yuan, Huang, Yi-Hsiang, Lin, Han-Chieh, Chiou, Yi-You, Lee, Fa-Yauh, Huo, Teh-Ia
Publicado 2015

Uncompromised Treatment Efficacy in Elderly Patients With Hepatocellular Carcinoma: A Propensity Score Analysis

por Liu, Po-Hong, Hsu, Chia-Yang, Lee, Yun-Hsuan, Hsia, Cheng-Yuan, Huang, Yi-Hsiang, Su, Chien-Wei, Chiou, Yi-You, Lin, Han-Chieh, Huo, Teh-Ia
Publicado 2014

Hong Kong Liver Cancer Staging System Is Associated With Better Performance for Hepatocellular Carcinoma: Special Emphasis on Viral Etiology

por Liu, Po-Hong, Hsu, Chia-Yang, Lee, Yun-Hsuan, Su, Chien-Wei, Hsia, Cheng-Yuan, Huang, Yi-Hsiang, Chiou, Yi-You, Lin, Han-Chieh, Huo, Teh-Ia
Publicado 2015

Solitary Large Hepatocellular Carcinoma: Staging and Treatment Strategy

por Liu, Po-Hong, Su, Chien-Wei, Hsu, Chia-Yang, Hsia, Cheng-Yuan, Lee, Yun-Hsuan, Huang, Yi-Hsiang, Lee, Rheun-Chuan, Lin, Han-Chieh, Huo, Teh-Ia
Publicado 2016

When to Perform Surgical Resection or Radiofrequency Ablation for Early Hepatocellular Carcinoma?: A Nomogram-guided Treatment Strategy

por Liu, Po-Hong, Hsu, Chia-Yang, Lee, Yun-Hsuan, Hsia, Cheng-Yuan, Huang, Yi-Hsiang, Su, Chien-Wei, Chiou, Yi-You, Lin, Han-Chieh, Huo, Teh-Ia
Publicado 2015

Prognostic impact of diabetes mellitus on hepatocellular carcinoma: Special emphasis from the BCLC perspective

por Su, Yu-Wen, Liu, Po-Hong, Hsu, Chia-Yang, Lee, Yun-Hsuan, Hsia, Cheng-Yuan, Ho, Shu-Yein, Hou, Ming-Chih, Chen, Harn-Shen, Huo, Teh-Ia
Publicado 2017

Survival of Patients with Hepatocellular Carcinoma in Renal Insufficiency: Prognostic Role of Albumin-Bilirubin Grade

por Ho, Shu-Yein, Hsu, Chia-Yang, Liu, Po-Hong, Ko, Chih-Chieh, Huang, Yi-Hsiang, Su, Chien-Wei, Lee, Rheun-Chuan, Hou, Ming-Chih, Huo, Teh-Ia
Publicado 2020

Hepatic Steatosis Is Associated with Increased Disease Severity and Liver Injury in Coronavirus Disease-19

por Chen, Vincent L., Hawa, Fadi, Berinstein, Jeffrey A., Reddy, Chanakyaram A., Kassab, Ihab, Platt, Kevin D., Hsu, Chia-Yang, Steiner, Calen A., Louissaint, Jeremy, Gunaratnam, Naresh T., Sharma, Pratima
Publicado 2020

Using nomogram of the Barcelona Clinic Liver Cancer system for treatment selection in patients with stage C hepatocellular carcinoma

por Hsu, Chia-Yang, Liu, Po-Hong, Ho, Shu-Yein, Hsia, Cheng-Yuan, Kudaravalli, Praneeth, Lee, Yun-Hsuan, Chiou, Yi-You, Tsai, Ya-Ju, Huang, Yi-Hsiang, Huo, Teh-Ia
Publicado 2018

A New Child-Turcotte-Pugh Class 0 for Patients with Hepatocellular Carcinoma: Determinants, Prognostic Impact and Ability to Improve the Current Staging Systems

por Lee, Yun-Hsuan, Hsu, Chia-Yang, Chu, Chen-Wei, Liu, Po-Hong, Hsia, Cheng-Yuan, Huang, Yi-Hsiang, Su, Chien-Wei, Chiou, Yi-You, Lin, Han-Chieh, Huo, Teh-Ia
Publicado 2014

Prognostic Performance of Ten Liver Function Models in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation

por Ho, Shu-Yein, Liu, Po-Hong, Hsu, Chia-Yang, Chiou, Yi-You, Su, Chien-Wei, Lee, Yun-Hsuan, Huang, Yi-Hsiang, Lee, Fa-Yauh, Hou, Ming-Chih, Huo, Teh-Ia
Publicado 2018